Publicacions en col·laboració amb investigadors/es de University Hospital of Bern (6)

2023

  1. Neuroblastoma RAS viral oncogene homolog (N-RAS) deficiency aggravates liver injury and fibrosis

    Cell death & disease, Vol. 14, Núm. 8, pp. 514

2021

  1. Assessing the impact of COVID-19 on liver cancer management (CERO-19)

    JHEP Reports, Vol. 3, Núm. 3

  2. The effect of early treatment with ivermectin on viral load, symptoms and humoral response in patients with non-severe COVID-19: A pilot, double-blind, placebo-controlled, randomized clinical trial

    EClinicalMedicine, Vol. 32

2018

  1. Gut roundtable meeting paper: Selected recent advances in hepatocellular carcinoma

    Gut, Vol. 67, Núm. 2, pp. 380-388

2016

  1. Assessment of the Hong Kong Liver Cancer Staging System in Europe

    Liver International, Vol. 36, Núm. 6, pp. 911-917

2012

  1. Heterogeneity of patients with intermediate (BCLC B) hepatocellular carcinoma: Proposal for a subclassification to facilitate treatment decisions

    Seminars in Liver Disease, Vol. 32, Núm. 4, pp. 348-359